NCT00667979View on ClinicalTrials.gov

Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse

PHASE4CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

December 31, 2004

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

10mg and 20mg to be taken 12, 18, 24 hours prior to sexual intercourse

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY

NCT00667979 - Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse | Biotech Hunter | Biotech Hunter